金磚5國(巴西、俄羅斯、印度、中國、南非)的組織學·細胞學市場預測:∼2017年

金磚5國(巴西、俄羅斯、印度、中國、南非)的組織學·細胞學市場預測:∼2017年 是由出版商GlobalData在2012年01月所出版的。 這份英文市場調查報告書包含Pages: 115 價格從美金2500起跳。

簡介

本報告提供金磚5國(巴西、俄羅斯、印度、中國、南非)各國的組織學·細胞學市場相關資料，金磚5國整體，各分類以及各國分析，各類別的市場規模，提供關於收益的2003年到2010年的實際成果資料，以及到2017年為止的預測，加上主要企業的市場佔有率及流通佔有率資料等，為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 金磚5國的組織學·細胞學市場

• 整體收益:2003年∼2017年
• 企業佔有率:2009年∼2010年

第4章 巴西的組織學·細胞學市場

• 整體收益:2003年∼2017年
• 組織抗原配合試劑市場
  • 整體收益:2003年∼2017年
• 單株抗體市場
  • 整體收益:2003年∼2017年
• 流式細胞儀市場
• 流通佔有率:2009年∼2010年
• 企業佔有率:2009年∼2010年

第5章 俄羅斯的組織學·細胞學市場

• 整體收益:2003年∼2017年
• 組織抗原配合試劑市場
  • 整體收益:2003年∼2017年
• 單株抗體市場
  • 整體收益:2003年∼2017年
• 流式細胞儀市場
• 流通佔有率:2009年∼2010年
• 企業佔有率:2009年∼2010年

第6章 印度的組織學·細胞學市場

• 整體收益:2003年∼2017年
• 組織抗原配合試劑市場
  • 整體收益:2003年∼2017年
• 單株抗體市場
  • 整體收益:2003年∼2017年
• 流式細胞儀市場
• 流通佔有率:2009年∼2010年
• 企業佔有率:2009年∼2010年

第7章 中國的組織學·細胞學市場

• 整體收益:2003年∼2017年
• 組織抗原配合試劑市場
  • 整體收益:2003年∼2017年
• 單株抗體市場
  • 整體收益:2003年∼2017年
• 流式細胞儀市場
• 流通佔有率:2009年∼2010年
• 企業佔有率:2009年∼2010年

第8章 南非的組織學·細胞學市場

• 整體收益:2003年∼2017年
• 組織抗原配合試劑市場
  • 整體收益:2003年∼2017年
• 單株抗體市場
  • 整體收益:2003年∼2017年
• 流式細胞儀市場
• 流通佔有率:2009年∼2010年
• 企業佔有率:2009年∼2010年

第9章 金磚5國的組織學·細胞學市場上主要企業

• Becton, Dickinson and Company
• Beckman Coulter, Inc.
• Sysmex Corporation
• F. Hoffmann-La Roche Ltd.
• Life Technologies Corporation
• Bio-Rad Laboratories, Inc.
• Abbott Laboratories
• Danaher Corporation
• Hologic, Inc.
• Trivitron Healthcare Pvt Ltd.
• Thermo Fisher Scientific Inc.

第10章 附錄

圖表

目錄

Abstract

Histology And Cytology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Summary

GlobalData's new report, "Histology And Cytology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017" provides key market data on the Histology And Cytology market in the BRICS countries. The report provides value ($m) data for each segment and sub-segment within three market categories - Tissue Typing Reagents, Flow Cytometers and Monoclonal Antibodies. The report also provides company shares and distribution shares data for the overall Histology And Cytology market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world's most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older-a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It's estimated that shortly after 2020, India's population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.

Scope

• Market size data for Histology And Cytology market categories - Tissue Typing Reagents, Flow Cytometers and Monoclonal Antibodies.
• Annualized market revenues ($m) data for each of the segments and sub-segments within the three market categories. Data from 2003 to 2010, forecast forward for seven years to 2017.
• 2010 company shares and distribution shares data for the overall Histology And Cytology market in each of the aforementioned countries.
• Global corporate-level profiles of key companies operating within the Histology And Cytology market in BRICS.
• Key players covered include Becton, Dickinson and Company, Beckman Coulter, Inc., Sysmex Corporation, F. Hoffmann-La Roche Ltd., Life Technologies Corporation, Bio-Rad Laboratories, Inc., Abbott Laboratories and Danaher Corporation.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Histology And Cytology competitive landscape in BRICS.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

TOC

1 Table of Contents

1 Table of Contents 2

• 1.1 List of Tables 6
• 1.2 List of Figures 8

2 Introduction 10

• 2.1 What is This Report About? 10

3 Histology And Cytology in BRICS 11

• 3.1 Histology And Cytology, BRICS, Overall Revenue ($m), 2003-2017 11
• 3.2 Histology And Cytology, BRICS, Company share (2009-2010) 17

4 Histology And Cytology In Brazil 19

• 4.1 Histology And Cytology, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 19
• 4.2 Tissue Typing Reagents In Brazil 25
• 4.2.1 Tissue Typing Reagents, Brazil, Overall Revenue (2003-2017) 25
• 4.3 Monoclonal Antibodies In Brazil 27
• 4.3.1 Monoclonal Antibodies, Brazil, Overall Revenue (2003-2017) 27
• 4.4 Flow Cytometers In Brazil 29
• 4.4.1 Flow Cytometers, Brazil, Overall Revenue (2003-2017) 29
• 4.5 Histology And Cytology, Brazil, Distribution Share (2009-2010) 31
• 4.6 Histology And Cytology, Brazil, Company Share (2009-2010) 32

5 Histology And Cytology In Russian Federation 34

• 5.1 Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 34
• 5.2 Tissue Typing Reagents In Russian Federation 40
• 5.2.1 Tissue Typing Reagents, Russian Federation, Overall Revenue (2003-2017) 40
• 5.3 Flow Cytometers In Russian Federation 42
• 5.3.1 Flow Cytometers, Russian Federation, Overall Revenue (2003-2017) 42
• 5.4 Monoclonal Antibodies In Russian Federation 44
• 5.4.1 Monoclonal Antibodies, Russian Federation, Overall Revenue (2003-2017) 44
• 5.5 Histology And Cytology, Russian Federation, Distribution Share (2009-2010) 46
• 5.6 Histology And Cytology, Russian Federation, Company Share (2009-2010) 47

6 Histology And Cytology In India 49

• 6.1 Histology And Cytology, India, Overall Revenue ($m), USD Actual, 2003-2017 49
• 6.2 Tissue Typing Reagents In India 55
• 6.2.1 Tissue Typing Reagents, India, Overall Revenue (2003-2017) 55
• 6.3 Flow Cytometers In India 57
• 6.3.1 Flow Cytometers, India, Overall Revenue (2003-2017) 57
• 6.4 Monoclonal Antibodies In India 59
• 6.4.1 Monoclonal Antibodies, India, Overall Revenue (2003-2017) 59
• 6.5 Histology And Cytology, India, Distribution Share (2009-2010) 61
• 6.6 Histology And Cytology, India, Company Share (2009-2010) 62

7 Histology And Cytology In China 64

• 7.1 Histology And Cytology, China, Overall Revenue ($m), USD Actual, 2003-2017 64
• 7.2 Flow Cytometers In China 70
• 7.2.1 Flow Cytometers, China, Overall Revenue (2003-2017) 70
• 7.3 Tissue Typing Reagents In China 72
• 7.3.1 Tissue Typing Reagents, China, Overall Revenue (2003-2017) 72
• 7.4 Monoclonal Antibodies In China 74
• 7.4.1 Monoclonal Antibodies, China, Overall Revenue (2003-2017) 74
• 7.5 Histology And Cytology, China, Distribution Share (2009-2010) 76
• 7.6 Histology And Cytology, China, Company share (2009-2010) 77

8 Histology And Cytology In South Africa 79

• 8.1 Histology And Cytology, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 79
• 8.2 Tissue Typing Reagents In South Africa 84
• 8.2.1 Tissue Typing Reagents, South Africa, Overall Revenue (2003-2017) 84
• 8.3 Flow Cytometers In South Africa 86
• 8.3.1 Flow Cytometers, South Africa, Overall Revenue (2003-2017) 86
• 8.4 Monoclonal Antibodies In South Africa 88
• 8.4.1 Monoclonal Antibodies, South Africa, Overall Revenue (2003-2017) 88
• 8.5 Histology And Cytology, South Africa, Distribution Share (2009-2010) 90
• 8.6 Histology And Cytology, South Africa, Company share (2009-2010) 91

9 Overview of Key Companies in BRICS Histology And Cytology Market 93

• 9.1 Becton, Dickinson and Company 93
• 9.1.1 Company Overview 93
• 9.1.2 Share in the BRICS Histology And Cytology Market 94
• 9.2 Beckman Coulter, Inc. 95
• 9.2.1 Company Overview 95
• 9.2.2 Share in the BRICS Histology And Cytology Market 96
• 9.3 Sysmex Corporation 97
• 9.3.1 Company Overview 97
• 9.3.2 Share in the BRICS Histology And Cytology Market 98
• 9.4 F. Hoffmann-La Roche Ltd. 99
• 9.4.1 Company Overview 99
• 9.4.2 Share in the BRICS Histology And Cytology Market 100
• 9.5 Life Technologies Corporation 101
• 9.5.1 Company Overview 101
• 9.5.2 Share in the BRICS Histology And Cytology Market 102
• 9.6 Bio-Rad Laboratories, Inc. 103
• 9.6.1 Company Overview 103
• 9.6.2 Share in the BRICS Histology And Cytology Market 104
• 9.7 Abbott Laboratories 105
• 9.7.1 Company Overview 105
• 9.7.2 Share in the BRICS Histology And Cytology Market 106
• 9.8 Danaher Corporation 107
• 9.8.1 Company Overview 107
• 9.8.2 Share in the BRICS Histology And Cytology Market 108
• 9.9 Hologic, Inc. 109
• 9.9.1 Company Overview 109
• 9.10 Trivitron Healthcare Pvt Ltd. 109
• 9.10.1 Company Overview 109
• 9.11 Thermo Fisher Scientific Inc. 109
• 9.11.1 Company Overview 109

10 Appendix 110

• 10.1 Definitions of Markets Covered in the Report 111
• 10.1.1 Histology And Cytology 111
• 10.2 Research Methodology 112
• 10.3 Secondary Research 112
• 10.4 Primary Research 113
• 10.5 Models 113
• 10.6 Forecasts 114
• 10.7 Expert Panels 114
• 10.8 GlobalData Consulting 114
• 10.9 Currency Conversion 115
• 10.10 Contact Us 115
• 10.11 Disclaimer 115

List of Tables

1.1 List of Tables

• Table 1: Histology And Cytology, BRICS, Overall Revenue ($m), 2003-2017 12
• Table 2: Histology And Cytology, BRICS, Overall Revenue ($m), Historic, 2003-2010 14
• Table 3: Histology And Cytology, BRICS, Overall Revenue ($m), Forecast, 2010-2017 16
• Table 4: Histology And Cytology, BRICS, Company share by Revenue ($m), USD Actual, 2009-2010 18
• Table 5: Histology And Cytology, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 20
• Table 6: Histology And Cytology, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 22
• Table 7: Histology And Cytology, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 24
• Table 8: Tissue Typing Reagents, Brazil, Revenue ($m), Historic, 2003-2010 25
• Table 9: Tissue Typing Reagents, Brazil, Revenue ($m), Forecast, 2010-2017 26
• Table 10: Monoclonal Antibodies, Brazil, Revenue ($m), Historic, 2003-2010 27
• Table 11: Monoclonal Antibodies, Brazil, Revenue ($m), Forecast, 2010-2017 28
• Table 12: Flow Cytometers, Brazil, Revenue ($m), Historic, 2003-2010 29
• Table 13: Flow Cytometers, Brazil, Revenue ($m), Forecast, 2010-2017 30
• Table 14: Histology And Cytology, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 31
• Table 15: Histology And Cytology, Brazil, Company share by Revenue ($m), USD Actual, 2009-2010 33
• Table 16: Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 35
• Table 17: Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 37
• Table 18: Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 39
• Table 19: Tissue Typing Reagents, Russian Federation, Revenue ($m), Historic, 2003-2010 40
• Table 20: Tissue Typing Reagents, Russian Federation, Revenue ($m), Forecast, 2010-2017 41
• Table 21: Flow Cytometers, Russian Federation, Revenue ($m), Historic, 2003-2010 42
• Table 22: Flow Cytometers, Russian Federation, Revenue ($m), Forecast, 2010-2017 43
• Table 23: Monoclonal Antibodies, Russian Federation, Revenue ($m), Historic, 2003-2010 44
• Table 24: Monoclonal Antibodies, Russian Federation, Revenue ($m), Forecast, 2010-2017 45
• Table 25: Histology And Cytology, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 46
• Table 26: Histology And Cytology, Russian Federation, Company share by Revenue ($m), USD Actual, 2009-2010 48
• Table 27: Histology And Cytology, India, Overall Revenue ($m), USD Actual, 2003-2017 50
• Table 28: Histology And Cytology, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 52
• Table 29: Histology And Cytology, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 54
• Table 30: Tissue Typing Reagents, India, Revenue ($m), Historic, 2003-2010 55
• Table 31: Tissue Typing Reagents, India, Revenue ($m), Forecast, 2010-2017 56
• Table 32: Flow Cytometers, India, Revenue ($m), Historic, 2003-2010 57
• Table 33: Flow Cytometers, India, Revenue ($m), Forecast, 2010-2017 58
• Table 34: Monoclonal Antibodies, India, Revenue ($m), Historic, 2003-2010 59
• Table 35: Monoclonal Antibodies, India, Revenue ($m), Forecast, 2010-2017 60
• Table 36: Histology And Cytology, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 61
• Table 37: Histology And Cytology, India, Company Share by Revenue ($m), USD Actual 2009-2010 63
• Table 38: Histology And Cytology, China, Overall Revenue ($m), USD Actual, 2003-2017 65
• Table 39: Histology And Cytology, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 67
• Table 40: Histology And Cytology, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 69
• Table 41: Flow Cytometers, China, Revenue ($m), Historic, 2003-2010 70
• Table 42: Flow Cytometers, China, Revenue ($m), Forecast, 2010-2017 71
• Table 43: Tissue Typing Reagents, China, Revenue ($m), Historic, 2003-2010 72
• Table 44: Tissue Typing Reagents, China, Revenue ($m), Forecast, 2010-2017 73
• Table 45: Monoclonal Antibodies, China, Revenue ($m), Historic, 2003-2010 74
• Table 46: Monoclonal Antibodies, China, Revenue ($m), Forecast, 2010-2017 75
• Table 47: Histology And Cytology, China, Distribution Share by Revenue ($m), USD Actual, 2009-2010 76
• Table 48: Histology And Cytology, China, Company share by Revenue ($m), USD Actual 2009-2010 78
• Table 49: Histology And Cytology, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 79
• Table 50: Histology And Cytology, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 81
• Table 51: Histology And Cytology, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 83
• Table 52: Tissue Typing Reagents, South Africa, Revenue ($m) , Historic, 2003-2010 84
• Table 53: Tissue Typing Reagents, South Africa, Revenue ($m), Forecast, 2010-2017 85
• Table 54: Flow Cytometers, South Africa, Revenue ($m), Historic, 2003-2010 86
• Table 55: Flow Cytometers, South Africa, Revenue ($m), Forecast, 2010-2017 87
• Table 56: Monoclonal Antibodies, South Africa, Revenue ($m), Historic, 2003-2010 88
• Table 57: Monoclonal Antibodies, South Africa, Revenue ($m), Forecast, 2010-2017 89
• Table 58: Histology And Cytology, South Africa, Distribution Share by Revenue ($m), USD Actual, 2009-2010 90
• Table 59: Histology And Cytology, South Africa, Company share by Revenue ($m), USD Actual 2009-2010 92
• Table 60: Becton, Dickinson and Company, Revenue ($m), BRICS Histology And Cytology Market, 2010 94
• Table 61: Beckman Coulter, Inc., Revenue ($m), BRICS Histology And Cytology Market, 2010 96
• Table 62: Sysmex Corporation, Revenue ($m), BRICS Histology And Cytology Market, 2010 98
• Table 63: F. Hoffmann-La Roche Ltd., Revenue ($m), BRICS Histology And Cytology Market, 2010 100
• Table 64: Life Technologies Corporation, Revenue ($m), BRICS Histology And Cytology Market, 2010 102
• Table 65: Bio-Rad Laboratories, Inc., Revenue ($m), BRICS Histology And Cytology Market, 2010 104
• Table 66: Abbott Laboratories, Revenue ($m), BRICS Histology And Cytology Market, 2010 106
• Table 67: Danaher Corporation, Revenue ($m), BRICS Histology And Cytology Market, 2010 108
• Table 68: USD to Local Currency, BRICS, Average Exchange Rate, 2003-2010 115

List of Figures

1.2 List of Figures

• Figure 1: Histology And Cytology, BRICS, Overall Revenue ($m), 2003-2017 11
• Figure 2: Histology And Cytology, BRICS, Overall Revenue ($m), Historic, 2003-2010 13
• Figure 3: Histology And Cytology, BRICS, Overall Revenue ($m), Forecast, 2010-2017 15
• Figure 4: Histology And Cytology, BRICS, Company share (%), 2010 17
• Figure 5: Histology And Cytology, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 19
• Figure 6: Histology And Cytology, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 21
• Figure 7: Histology And Cytology, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 23
• Figure 8: Tissue Typing Reagents, Brazil, Revenue ($m), Historic, 2003-2010 25
• Figure 9: Tissue Typing Reagents, Brazil, Revenue ($m), Forecast, 2010-2017 26
• Figure 10: Monoclonal Antibodies, Brazil, Revenue ($m), Historic, 2003-2010 27
• Figure 11: Monoclonal Antibodies, Brazil, Revenue ($m), Forecast, 2010-2017 28
• Figure 12: Flow Cytometers, Brazil, Revenue ($m), Historic, 2003-2010 29
• Figure 13: Flow Cytometers, Brazil, Revenue ($m), Forecast, 2010-2017 30
• Figure 14: Histology And Cytology, Brazil, Company share (%), 2010 32
• Figure 15: Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 34
• Figure 16: Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 36
• Figure 17: Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 38
• Figure 18: Tissue Typing Reagents, Russian Federation, Revenue ($m), Historic, 2003-2010 40
• Figure 19: Tissue Typing Reagents, Russian Federation, Revenue ($m), Forecast, 2010-2017 41
• Figure 20: Flow Cytometers, Russian Federation, Revenue ($m), Historic, 2003-2010 42
• Figure 21: Flow Cytometers, Russian Federation, Revenue ($m), Forecast, 2010-2017 43
• Figure 22: Monoclonal Antibodies, Russian Federation, Revenue ($m), Historic, 2003-2010 44
• Figure 23: Monoclonal Antibodies, Russian Federation, Revenue ($m), Forecast, 2010-2017 45
• Figure 24: Histology And Cytology, Russian Federation, Company share (%), 2010 47
• Figure 25: Histology And Cytology, India, Overall Revenue ($m), USD Actual, 2003-2017 49
• Figure 26: Histology And Cytology, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 51
• Figure 27: Histology And Cytology, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 53
• Figure 28: Tissue Typing Reagents, India, Revenue ($m), Historic, 2003-2010 55
• Figure 29: Tissue Typing Reagents, India, Revenue ($m), Forecast, 2010-2017 56
• Figure 30: Flow Cytometers, India, Revenue ($m), Historic, 2003-2010 57
• Figure 31: Flow Cytometers, India, Revenue ($m), Forecast, 2010-2017 58
• Figure 32: Monoclonal Antibodies, India, Revenue ($m), Historic, 2003-2010 59
• Figure 33: Monoclonal Antibodies, India, Revenue ($m), Forecast, 2010-2017 60
• Figure 34: Histology And Cytology, India, Company Share (%), 2010 62
• Figure 35: Histology And Cytology, China, Overall Revenue ($m), USD Actual, 2003-2017 64
• Figure 36: Histology And Cytology, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 66
• Figure 37: Histology And Cytology, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 68
• Figure 38: Flow Cytometers, China, Revenue ($m), Historic, 2003-2010 70
• Figure 39: Flow Cytometers, China, Revenue ($m), Forecast, 2010-2017 71
• Figure 40: Tissue Typing Reagents, China, Revenue ($m), Historic, 2003-2010 72
• Figure 41: Tissue Typing Reagents, China, Revenue ($m), Forecast, 2010-2017 73
• Figure 42: Monoclonal Antibodies, China, Revenue ($m), Historic, 2003-2010 74
• Figure 43: Monoclonal Antibodies, China, Revenue ($m), Forecast, 2010-2017 75
• Figure 44: Histology And Cytology, China, Company share (%), 2010 77
• Figure 45: Histology And Cytology, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 79
• Figure 46: Histology And Cytology, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 80
• Figure 47: Histology And Cytology, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 82
• Figure 48: Tissue Typing Reagents, South Africa, Revenue ($m), Historic, 2003-2010 84
• Figure 49: Tissue Typing Reagents, South Africa, Revenue ($m), Forecast, 2010-2017 85
• Figure 50: Flow Cytometers, South Africa, Revenue ($m), Historic, 2003-2010 86
• Figure 51: Flow Cytometers, South Africa, Revenue ($m), Forecast, 2010-2017 87
• Figure 52: Monoclonal Antibodies, South Africa, Revenue ($m), Historic, 2003-2010 88
• Figure 53: Monoclonal Antibodies, South Africa, Revenue ($m), Forecast, 2010-2017 89
• Figure 54: Histology And Cytology, South Africa, Company share (%), 2010 91
• Figure 55: Becton, Dickinson and Company, Company Share (%), BRICS Histology And Cytology Market, 2010 94
• Figure 56: Beckman Coulter, Inc., Company Share (%), BRICS Histology And Cytology Market, 2010 96
• Figure 57: Sysmex Corporation, Company Share (%), BRICS Histology And Cytology Market, 2010 98
• Figure 58: F. Hoffmann-La Roche Ltd., Company Share (%), BRICS Histology And Cytology Market, 2010 100
• Figure 59: Life Technologies Corporation, Company Share (%), BRICS Histology And Cytology Market, 2010 102
• Figure 60: Bio-Rad Laboratories, Inc., Company Share (%), BRICS Histology And Cytology Market, 2010 104
• Figure 61: Abbott Laboratories, Company Share (%), BRICS Histology And Cytology Market, 2010 106
• Figure 62: Danaher Corporation, Company Share (%), BRICS Histology And Cytology Market, 2010 108

相關商品

GlobalData發行的生物科技相關市場調查報告書

免疫化學分析儀與檢查套件:全球性開發平台分析，競爭情形，到2018年為止的市場未來預測

Immunochemistry Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

價格 : US $ 3995

出版日期 : 2012年04月

金磚5國(巴西·俄羅斯·印度·中國·南非)臨床化學市場:到2017年為止的展望

Clinical Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

價格 : US $ 2500

出版日期 : 2012年03月

沙烏地阿拉伯的體外診斷市場預測:臨床化學檢驗·遺傳基因檢驗·血液檢驗·組織/細胞檢驗，免疫化學檢查·感染/免疫疾病檢驗·微生物學培養檢驗

Saudi Arabia In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

價格 : US $ 2500

出版日期 : 2012年01月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!